IL11 and COVID-19: Further studies using e.g. bronchoalveolar lavage or even tissue biopsies from patients would be able to determine whether IL-11 might be present in higher amounts locally in the lung tissue of COVID-19 patients and thereby contribute to inflammatory or pro-fibrotic processes.